Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder
NCT00593099Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Apr 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in nicotine dependence, sponsored by National Institute on Drug Abuse. Started Apr 2004; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00593099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593099.